Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

May 10, 2022

Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 5, 2022

Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease
May 3, 2022

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
April 25, 2022

Immunic, Inc. to Participate in Upcoming Investor and Industry Conferences
March 16, 2022

Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer

Show per page